NIHR Global Health Research Unit on Genomic Surveillance of Antimicrobial Resistance Showcase (EN)

English Subtitles
RSTMH is delighted to partner with the NIHR funded Global Health Research Unit on Genomic Surveillance of AMR (Antimicrobial Resistance) for this virtual event that will showcase the outputs of the GHRU on Genomic Surveillance of AMR and share experience and learnings about the practical implementation of whole genome sequencing (WGS) for the surveillance of AMR.

RSTMH has a strong interest in AMR, as one of our Strategic Priorities in our current Strategy and having held our last Annual Meeting on this topic. This is our first work in partnership with the NIHR Global Health Research Unit on Genomic Surveillance of AMR and we are pleased to able to bring awareness of their work to our networks.

The National Institute for Health and Care Research (NIHR) Global Health Research Unit (GHRU) on Genomic Surveillance of AMR was initiated to focus on the implementation and integration of WGS within existing or nascent national AMR surveillance systems and to define standard methodologies, technical packages, and workstreams that would enhance the ability to both deliver WGS as a practical local tool and to bring together data and interpretation of pathogen dynamics for local, national, and international utility.

With a growing interest and momentum around genomics for infectious disease surveillance, this showcase will present the very practical considerations around implementing WGS and building capacity in genomic pathogen surveillance, with learnings from four different settings (Philippines, Colombia, Nigeria, and India). While each place is at a different stage of national AMR surveillance, and each has different institutional fingerprints; the GHRU has identified horizontal technical and data requirements and has developed approaches that can be applied vertically within different backgrounds. The issues covered will be capacity building around laboratory, bioinformatics, training, as well as financial/ grant management capacity in global health. The other aspect that will be presented is the value and outputs derived by each partner in the GHRU from the use of WGS, through the lens of K. pneumoniae genomics; as well as the global value derived from local genomics surveillance efforts.

The event will be of relevance for a wide audience whether researchers, public health professionals, or policy makers and including those with an interest in AMR and/or infectious disease genomics.

The NIHR Global Health Research Unit on Genomic Surveillance of AMR- Implementing Whole Genome Sequencing for Surveillance of Antimicrobial Resistance: Local and International Insights Into Klebsiella pneumoniae Supplement articles can be found here